Literature DB >> 21668634

Acute renal endothelial injury during marrow recovery in a cohort of combined kidney and bone marrow allografts.

A B Farris1, D Taheri, T Kawai, L Fazlollahi, W Wong, N Tolkoff-Rubin, T R Spitzer, A J Iafrate, F I Preffer, S A Locascio, B Sprangers, S Saidman, R N Smith, A B Cosimi, M Sykes, D H Sachs, R B Colvin.   

Abstract

An idiopathic capillary leak syndrome ('engraftment syndrome') often occurs in recipients of hematopoietic cells, manifested clinically by transient azotemia and sometimes fever and fluid retention. Here, we report the renal pathology in 10 recipients of combined bone marrow and kidney allografts. Nine developed graft dysfunction on day 10-16 and renal biopsies showed marked acute tubular injury, with interstitial edema, hemorrhage and capillary congestion, with little or no interstitial infiltrate (≤10%) and marked glomerular and peritubular capillary (PTC) endothelial injury and loss by electron microscopy. Two had transient arterial endothelial inflammation; and 2 had C4d deposition. The cells in capillaries were primarily CD68(+) MPO(+) mononuclear cells and CD3(+) CD8(+) T cells, the latter with a high proliferative index (Ki67(+) ). B cells (CD20(+) ) and CD4(+) T cells were not detectable, and NK cells were rare. XY FISH showed that CD45(+) cells in PTCs were of recipient origin. Optimal treatment remains to be defined; two recovered without additional therapy, six were treated with anti-rejection regimens. Except for one patient, who later developed thrombotic microangiopathy and one with acute humoral rejection, all fully recovered within 2-4 weeks. Graft endothelium is the primary target of this process, attributable to as yet obscure mechanisms, arising during leukocyte recovery. ©2011 The Authors Journal compilation©2011 The American Society of Transplantation and the American Society of Transplant Surgeons.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21668634      PMCID: PMC3128680          DOI: 10.1111/j.1600-6143.2011.03572.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  50 in total

1.  Homeostatic proliferation of lymphocytes results in augmented memory-like function and accelerated allograft rejection.

Authors:  Victoria F Moxham; Julieta Karegli; Richard E Phillips; Kathryn L Brown; Thomas T Tapmeier; Robert Hangartner; Steven H Sacks; Wilson Wong
Journal:  J Immunol       Date:  2008-03-15       Impact factor: 5.422

2.  Early complications following haematopoietic SCT in children.

Authors:  M Miano; M Faraci; G Dini; P Bordigoni
Journal:  Bone Marrow Transplant       Date:  2008-06       Impact factor: 5.483

3.  Influence of cyclophosphamide and its metabolic products on the activity of peritoneal macrophages in mice.

Authors:  Krzysztof Bryniarski; Marian Szczepanik; Maria Ptak; Magdalena Zemelka; Włodzimierz Ptak
Journal:  Pharmacol Rep       Date:  2009 May-Jun       Impact factor: 3.024

4.  Eruption of lymphocyte recovery or autologous graft-versus-host disease?

Authors:  Ruud G L Nellen; Arienne M W van Marion; Jorge Frank; Pamela Poblete-Gutiérrez; Peter M Steijlen
Journal:  Int J Dermatol       Date:  2008-11       Impact factor: 2.736

5.  HLA-mismatched renal transplantation without maintenance immunosuppression.

Authors:  Tatsuo Kawai; A Benedict Cosimi; Thomas R Spitzer; Nina Tolkoff-Rubin; Manikkam Suthanthiran; Susan L Saidman; Juanita Shaffer; Frederic I Preffer; Ruchuang Ding; Vijay Sharma; Jay A Fishman; Bimalangshu Dey; Dicken S C Ko; Martin Hertl; Nelson B Goes; Waichi Wong; Winfred W Williams; Robert B Colvin; Megan Sykes; David H Sachs
Journal:  N Engl J Med       Date:  2008-01-24       Impact factor: 91.245

6.  Plasma elevations of tumor necrosis factor-receptor-1 at day 7 postallogeneic transplant correlate with graft-versus-host disease severity and overall survival in pediatric patients.

Authors:  Carrie L Kitko; Sophie Paczesny; Gregory Yanik; Thomas Braun; Dawn Jones; Joel Whitfield; Sung W Choi; Raymond J Hutchinson; James L M Ferrara; John E Levine
Journal:  Biol Blood Marrow Transplant       Date:  2008-07       Impact factor: 5.742

Review 7.  Vascular endothelium as 'novel' target of graft-versus-host disease.

Authors:  André Tichelli; Alois Gratwohl
Journal:  Best Pract Res Clin Haematol       Date:  2008-06       Impact factor: 3.020

Review 8.  Autoimmune disease after autologous hematopoietic stem cell transplantation.

Authors:  Toshiyuki Bohgaki; Tatsuya Atsumi; Takao Koike
Journal:  Autoimmun Rev       Date:  2007-12-03       Impact factor: 9.754

9.  Clinical characteristics of thrombotic microangiopathy following ABO incompatible living donor liver transplantation.

Authors:  Ryohei Miyata; Motohide Shimazu; Minoru Tanabe; Shigeyuki Kawachi; Ken Hoshino; Go Wakabayashi; Yoko Kawai; Masaki Kitajima
Journal:  Liver Transpl       Date:  2007-10       Impact factor: 5.799

10.  Renal pathology in hematopoietic cell transplantation recipients.

Authors:  Megan L Troxell; Maricel Pilapil; David B Miklos; John P Higgins; Neeraja Kambham
Journal:  Mod Pathol       Date:  2008-01-25       Impact factor: 7.842

View more
  35 in total

1.  Evidence for kidney rejection after combined bone marrow and renal transplantation despite ongoing whole-blood chimerism in rhesus macaques.

Authors:  S K Ramakrishnan; A Page; A B Farris; K Singh; F Leopardi; K Hamby; S Sen; A Polnett; T Deane; M Song; L Stempora; E Strobert; A D Kirk; C P Larsen; L S Kean
Journal:  Am J Transplant       Date:  2012-05-29       Impact factor: 8.086

Review 2.  Mesenchymal stromal cells in renal transplantation: opportunities and challenges.

Authors:  Federica Casiraghi; Norberto Perico; Monica Cortinovis; Giuseppe Remuzzi
Journal:  Nat Rev Nephrol       Date:  2016-02-08       Impact factor: 28.314

3.  Twenty-year Follow-up of Histocompatibility Leukocyte Antigen-matched Kidney and Bone Marrow Cotransplantation for Multiple Myeloma With End-stage Renal Disease: Lessons Learned.

Authors:  Thomas R Spitzer; Nina Tolkoff-Rubin; A Benedict Cosimi; Steven McAfee; Bimalangshu R Dey; Yi-Bin Chen; Francis Delmonico; Megan Sykes; David H Sachs; Tatsuo Kawai
Journal:  Transplantation       Date:  2019-11       Impact factor: 4.939

4.  Effect of Timing and Complement Receptor Antagonism on Intragraft Recruitment and Protolerogenic Effects of Mesenchymal Stromal Cells in Murine Kidney Transplantation.

Authors:  Federica Casiraghi; Marta Todeschini; Nadia Azzollini; Paolo Cravedi; Paola Cassis; Samantha Solini; Sonia Fiori; Cinzia Rota; Aida Karachi; Camillo Carrara; Marina Noris; Norberto Perico; Giuseppe Remuzzi
Journal:  Transplantation       Date:  2019-06       Impact factor: 4.939

5.  HLA-mismatched renal transplantation without maintenance immunosuppression.

Authors:  Tatsuo Kawai; David H Sachs; Megan Sykes; A Benedict Cosimi
Journal:  N Engl J Med       Date:  2013-05-09       Impact factor: 91.245

Review 6.  What's new in clinical solid organ transplantation by 2013.

Authors:  Maurizio Salvadori; Elisabetta Bertoni
Journal:  World J Transplant       Date:  2014-12-24

Review 7.  Engraftment syndrome: double-edged sword of hematopoietic cell transplants.

Authors:  T R Spitzer
Journal:  Bone Marrow Transplant       Date:  2015-01-12       Impact factor: 5.483

8.  The role of donor-derived veto cells in nonmyeloablative haploidentical HSCT.

Authors:  N Or-Geva; Y Reisner
Journal:  Bone Marrow Transplant       Date:  2015-06       Impact factor: 5.483

9.  Simultaneous bone marrow and composite tissue transplantation in rats treated with nonmyeloablative conditioning promotes tolerance.

Authors:  Hong Xu; Deborah M Ramsey; Shengli Wu; Larry D Bozulic; Suzanne T Ildstad
Journal:  Transplantation       Date:  2013-01-27       Impact factor: 4.939

10.  Tolerance induction in HLA disparate living donor kidney transplantation by donor stem cell infusion: durable chimerism predicts outcome.

Authors:  Joseph Leventhal; Michael Abecassis; Joshua Miller; Lorenzo Gallon; David Tollerud; Mary Jane Elliott; Larry D Bozulic; Christopher Houston; Nedjema Sustento-Reodica; Suzanne T Ildstad
Journal:  Transplantation       Date:  2013-01-15       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.